NCT04194086View on ClinicalTrials.gov

Population Pharmacokinetics and Safety of Oral Posaconazole in Children With Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

July 1, 2021

Study Completion Date

July 30, 2021

Conditions

Leukemia, Acute

Interventions

DRUG

posaconazole oral suspensions

posaconazole oral suspensions（5mg/kg/d,tid) will be administered specially febrile neutropenia patients four times a day and blood samples will be taken any hours after the first dose at least Day 7.

Trial Locations (1)

Unknown

Zhujiang Hospital of Southern Medical University, Guanzhou

All Listed Sponsors

collaborator

Guangdong Provincial People's Hospital

OTHER

lead

Zhujiang Hospital

OTHER

NCT04194086 - Population Pharmacokinetics and Safety of Oral Posaconazole in Children With Leukemia | Biotech Hunter | Biotech Hunter